X

pharmaceuticals

Earnings Infographic: Highlights of Danaher Corporation’s (DHR) Q4 results

Danaher Corporation (NYSE: DHR), a provider of industrial and medical products, reported higher sales and net profit for the fourth quarter of…

JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2022 earnings results

Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2022 earnings results today. Reported sales decreased 4.4% year-over-year to $23.7…

Cadrenal Therapeutics downsizes IPO, looks to raise $7 million

There has been an increase in the number of pharma companies taking the IPO route to enhance their research and…

Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent…

Nava Health to go public with a $12Mln IPO. Here’s all you need to know

With only a few days left for 2022 to end, there aren't many initial public offerings scheduled for the rest…

Cancer drug maker Felicitex prepares for IPO. Here’s all you need to know

Fewer companies filed for initial public offering this year, compared to 2021 when the market witnessed a record number of…

Catalyst Pharmaceuticals Inc (CPRX) Q3 2022 Earnings Call Transcript

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Q3 2022 Earnings Call dated Nov. 10, 2022. Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer…

ANI Pharmaceuticals Inc (ANIP) Q3 2022 Earnings Call Transcript

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and…

PetIQ Inc (PETQ) Q3 2022 Earnings Call Transcript

PetIQ Inc (NASDAQ:PETQ) Q3 2022 Earnings Call dated Nov. 09, 2022.   Corporate Participants: Katie Turner -- Investor Relations Executive McCord Christensen -- Chief…

Jazz Pharmaceuticals PLC (JAZZ) Q3 2022 Earnings Call Transcript

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Andrea N. Flynn -- Vice President, Head, Investor…

Perrigo Co PLC (PRGO) Q3 2022 Earnings Call Transcript

Perrigo Co PLC (NYSE:PRGO) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations…

Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows

Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile,…

Zoetis Inc (ZTS) Q3 2022 Earnings Call Transcript

Zoetis Inc (NYSE:ZTS) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Steve Frank -- Vice President of Investor Relations Kristin…

Consider these factors before investing in Eli Lilly and Company (LLY)

The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant…

Eli Lilly and Company (LLY) Q3 2022 Earnings Call Transcript

Eli Lilly and Company (NYSE:LLY) Q3 2022 Earnings Call dated Nov. 01, 2022. Corporate Participants: Joe Fletcher -- Senior Vice President, Investor…

Four noteworthy points from Pfizer’s (PFE) Q3 2022 earnings report

Shares of Pfizer Inc. (NYSE: PFE) were up 3% on Tuesday after the company beat estimates for the third quarter…

Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The…

Pfizer (PFE) Q3 2022 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net…

ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while…

Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

BIIB Stock: Is Biogen an investment worth trying now?

Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced…